Stay updated on Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision metadata updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:12.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the prior v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:57:07.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added. The previous notice about a lapse in government funding and related operating status information (Revision: v3.4.1) was removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:07:25.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added. The revision tag changed from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T22:36:02.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated footer labels to 'Last Update Submitted that Met QC Criteria' with a 'Revision: v3.4.0' note.
    Difference
    0.2%
    Check dated 2026-01-27T16:59:17.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4; no trial details or visible content were modified.
    Difference
    0.1%
    Check dated 2026-01-20T15:40:53.000Z thumbnail image

Stay in the know with updates to Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.